Drug combination reaches key threshold for ‘functional cure’ of chronic liver infection that affects more than 250 million ...

Aligos Therapeutics focuses on ALG-000184 for CHB and ALG-055009 for MASH, targeting large, underserved markets with growing ...

The TIME is a dynamic network composed of cancer cells, immune cells, and stromal components. During the early stages of tumorigenesis, the TIME ...

An estimated 100 million Americans have some form of liver disease, yet only 4.5 million U.S. adults have received a formal ...

The combined company, which will pair Chroma’s epigenetic editing with Nvelop’s non-viral particles, has raised $75 million ...

Chroma Medicine and Nvelop Therapeutics have merged to form nChroma Bio and rounded up a $75 million financing.

Baxter International Inc. , a global leader in injectables, anesthesia and drug compounding, today announced five new injectable pharmaceutical product launches in the U.S., joining the previous five ...